MAXVAX
MAXVAX
Industry:
Biotechnology Health Care
Founded:
2016-01-01
Address:
Shuangliu, Sichuan, China
Country:
China
Website Url:
http://www.maxvax.cn
Status:
Active
Contact:
028-85329858
Total Funding:
74.06 M USD
Investors List
Fangshizhen Capital
Fangshizhen Capital investment in Series B - MAXVAX
China Life Private Equity Investment
China Life Private Equity Investment investment in Series B - MAXVAX
Hillhouse Capital Group
Hillhouse Capital Group investment in Series B - MAXVAX
Xinshang
Xinshang investment in Series B - MAXVAX
Sherpa Invest
Sherpa Invest investment in Series B - MAXVAX
Sherpa Venture Capital
Sherpa Venture Capital investment in Series A - MAXVAX
Hillhouse Capital Group
Hillhouse Capital Group investment in Series A - MAXVAX
Korea Investment Partners
Korea Investment Partners investment in Series A - MAXVAX
Official Site Inspections
http://www.maxvax.cn
- Host name: 211.149.238.101
- IP address: 211.149.238.101
- Location: China
- Latitude: 34.7725
- Longitude: 113.7266
- Timezone: Asia/Shanghai
More informations about "MAXVAX"
迈科康生物 - maxvax.cn
平台优势. 基于国际领先的新型佐剂、重组蛋白平台，搭建了一系列重大创新疫苗品种管线。拥有近20种佐剂原材料，打造了3类成熟的传送系统，开发了10多种新型佐剂系统，形成从佐剂原 …See details»
MAXVAX - Crunchbase Company Profile & Funding
Founded Date 2016. Operating Status Active. Last Funding Type Series C. Also Known As MaxHealth Biotechnology, Mycocon Biotech, Meikekang Biotechnology. Legal Name Chengdu Meikekang Biotechnology Co., Ltd. …See details»
Maxvax Health - PitchBook
1. Seed Round. Developer of rotavirus, shingles and herpes vaccine technology intended to serve the biotechnology industry. The company. One of Maxvax Health’s 2 competitors is MingMed, …See details»
Chengdu Maxvax Biotechnology LLC - synapse.zhihuiya.com
了解Chengdu Maxvax Biotechnology LLC (成都迈科康生物科技有限公司)公司的药物管线，治疗领域，技术平台，以及它的13项临床试验, 58篇新闻和2篇文献，疾病领域:感染，肿瘤，技术平 …See details»
Maxvax Biology opens vaccine production platform in Lin-gang
Maxvax Biology Technology Co Ltd is a Chengdu-based biopharmaceutical company that undertakes research and development, production and commercialization of innovative …See details»
Maxvax Biotechnology Ltd. | Insights
Jul 7, 2024 · Hangzhou- Scrip. Three Chinese Biotechs Bag Late-Stage VC/PE Funding In February. 06 Mar 2024. • By Dexter Jie Yan. Venture Capital and private equity investors in …See details»
MAXVAX - Updates, News, Events, Signals & Triggers - Crunchbase
Maxvax Biotechnology, a Chinese developer of innovative vaccines and immunotherapies targeting infectious diseases and cancer, has closed an IDG Capital-led funding round. See …See details»
Vaccines Developer Maxvax Closes a Nearly CNY 500 Million …
Jul 21, 2022 · Maxvax, a developer of innovative vaccines and new adjuvants, announced the completion of nearly CNY 500 million in Series B round of funding.See details»
Chinese Biotechs Garner Millions for Shingles Vaccine Candidate …
Jul 22, 2022 · Chinese companies Maxvax Biotechnology and Beijing Luzhu Biotechnology are raising funds to move their respective research and development programs for recombinant …See details»
Shanghai Maikekang Biotechnology Co., Ltd. - synapse-zhihuiya …
7. 项与 上海迈科康生物科技有限公司 相关的临床试验. CTR20241986 / Recruiting临床3期. 多中心、随机、双盲、安慰剂对照设计评价重组带状疱疹疫苗（CHO 细胞）在 40 周岁及以上人群中 …See details»
MAXVAX Biotechnology Limited Liability Company | Bill & Melinda …
MAXVAX Biotechnology Limited Liability Company. Grantee website Chengdu, SC, China. Purpose. To select and test antigens for a therapeutic HPV vaccine candidate. Division. …See details»
迈科康生物完成C系列融资，募集资金累计超6亿 - 投资界
Jul 10, 2024 · 迈科康生物成立于2016年，是一家致力于创新疫苗和新型佐剂研发、生产和商业化于一体的全球生物医药企业。 2024-07-10 15:17 投资界讯 MAXVAX. 投资 …See details»
迈科康生物 | 项目信息-36氪
迈科康是一家专注创新疫苗和新型佐剂研发的企业，公司拥有领先的创新佐剂技术平台和重组蛋白表达平台。 迈科康人用疫苗研发管线项目包括预防性和治疗性两类，预防性疫苗含多个重大 …See details»
MaxVax | CipherBio
Explore MaxVax's investment information, scientific platforms, therapeutic approaches, indications and more here!See details»
MaxHealth迈科康 | 项目信息-36氪
迈科康是一家专注创新疫苗和新型佐剂研发的企业，公司拥有领先的创新佐剂技术平台和重组蛋白表达平台。 迈科康人用疫苗研发管线项目包括预防性和治疗性两类，预防性疫苗含多个重大 …See details»
Two Chinese Biotechs Raise $104m To Challenge GSK’s Shingrix
Jul 22, 2022 · MAXVAX Biotechnology and Beijing Luzhu Biotechnology raise new funds to progress their recombinant herpes zoster vaccine candidates with novel adjuvants, while …See details»
迈科康完成数亿元 A 轮融资，推进创新疫苗项目临床研究和产业化 …
Jul 21, 2021 · 迈科康于2017年10月开始正式运营，专注于先进疫苗技术与产品的自主研发及整合创新，目前两个重磅疫苗项目即将进入临床研究阶段。 迈科康的核心技术是国内首创的创新 …See details»
从一间房到一个厂②|成都高新区迈科康生物：自主研发的轮状病毒 …
Jun 25, 2021 · “疫苗佐剂”是一种化学或生物的材料，作为辅料添加在疫苗中，对疫苗的有效性起着关键作用，“过去疫苗中常用的佐剂为氢氧化铝，但随着疫苗技术的不断深入探究，氢氧化铝 …See details»
MAXVAX Biotechnology - Company Profile - Tracxn
Nov 15, 2024 · MAXVAX Biotechnology - Developer of vaccines for infectious diseases. Raised a total funding of $84.8M over 6 rounds from 10 investors. Founded by Dexiang Chen in the …See details»
2025贵州高考考生资格申报入口（http://gkks.eaagz.org.cn）
3 days ago · 【导语】：贵州省2025年高考考生资格申报将于2024年11月25日至12月5日进行，考生可登录贵州省普通高校招生考试考生综合信息平台进行申报。 贵州省2025年高考考生资格 …See details»